Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2016 Oct 7;15(12):2863–2874. doi: 10.1158/1535-7163.MCT-16-0515

Figure 6. Effect of treatment with fisetin, cabazitaxel and their combination on proliferation, apoptosis, and tumor angiogenesis in a subcutaneous PC3M-luc-6 xenograft model.

Figure 6

At the end of study, tumors were harvested from mice, subjected to IHC for proliferation (anti-ki67 and anti-PCNA); metastasis (anti-MMP-9); angiogenesis (anti-CD31) and (anti-VEGF). Left, representative photomicrographs of Ki67, PCNA, MMP-9, CD31 and VEGF-stained tumor section (x 40). Right, quantitation of Ki67, PCNA, MMP-9, CD31 and VEGF; **, p ≤ 0.02, ***, p ≤ 0.001.